Thank you for your continued interest in Wegovy®. When we introduced this medicine in 2021, we saw significant interest from the healthcare community and patients, resulting in unprecedented product demand. Shortly thereafter, we experienced issues at the contract manufacturing site for Wegovy®, which resulted in supply shortages.
From the outset, our top priority has been to support current patients who have started treatment with Wegovy® to be able to advance through the dose escalation process and stay on therapy. We took several steps as part of that commitment. We asked healthcare providers to not start new patients on Wegovy®, we have not advertised or promoted it and more recently, we made the decision to temporarily stop shipments of the first two dose strengths (0.25 mg and 0.5 mg) — all to minimize demand from new patients and increase the likelihood there would be enough product available in the market to meet the needs of current Wegovy® patients.
Outages of the Wegovy® 1 mg dose strength
Despite these efforts, new prescriptions for Wegovy® continued to occur, resulting in product outages of the 1 mg dose. There will be minimal to no supply of the 1 mg dose strength beginning as early as May, and this will continue into the second half of 2022 when we expect to stabilize supply.
Currently, we are producing limited amounts of Wegovy® 1.7 and 2.4 mg dose strengths. We believe we can meet the needs of patients who are already taking or about to start the 1.7 or 2.4 mg dose strengths and remain confident in our ability to supply them, unless there are significant, unforeseen increases in prescriptions.
We sincerely regret this situation and apologize for any delay or disruption in treatment it may cause. If you have concerns, please contact your healthcare provider to determine the best approach for your treatment plan, in consideration of this supply situation.
Our efforts to restore supply
For patients currently taking Wegovy® please know that some pharmacies may continue to experience normal Wegovy® product delays from time-to-time given supply variability. We encourage patients to contact their local pharmacy in advance to confirm that the pharmacy will be able to fill your prescription.
We take our commitment to patients and the healthcare community very seriously and are doing everything we can to stabilize Wegovy® supply as quickly as possible. We believe the continued strong demand reflects the significant unmet medical need and the importance of this treatment option.
We appreciate your patience and understand your frustration. If you have concerns, we encourage you to speak to your healthcare provider about the weight management approach that is best for you.
We are here to help and are ready to answer your questions at 1-833-4-WEGOVY (1-833-493-4689) from 9 AM to 6 PM Eastern Monday through Friday – and select option 0 for more support.
If you have additional comments or would like to provide feedback on what other information would be helpful to you, please contact our Customer Care Center at 1-800-727-6500 or submit online. We will be reviewing that information on an ongoing basis and making periodic updates to this page. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. Thank you for your patience as we work to resolve this issue – which we will.
Your Career Guide